F-Prime Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 32
Professionals
  • Investments
  • 360
  • Portfolio
  • 144
  • Exits
  • 102
Exits

F-Prime Capital General Information

Description

Founded in 1969, F-Prime Capital is a global venture capital firm based in Cambridge, Massachusetts. The firm invests in the healthcare and technology.

Contact Information

Formerly Known As
Fidelity Biosciences
Year Founded
1969
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

F-Prime Capital Investments (360)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Atalanta Therapeutics 11-Jan-2021 Early Stage VC 00000 Biotechnology Startup 000000 00000000 00.0
0 000000 06-Jan-2021 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
0000000 07-Dec-2020 00000 00000 000.00 Managed Care Generating Revenue 00000000 000
000000000 01-Dec-2020 00000 00000 000.00 Financial Software Generating Revenue
000000 30-Nov-2020 0000 00000 00.000 Financial Software Generating Revenue
0000000 27-Oct-2020 00000 00000 000.00 Business/Productivity Software Generating Revenue
00000000 13-Oct-2020 00000 00000 0000 Financial Software Generating Revenue 00000 00000 00
000000 0000000 25-Sep-2020 00000 00000 0000 Software Development Applications Generating Revenue
Neurogeneus 16-Sep-2020 Seed Round 000.00 Other Commercial Products Stealth
Carrot (Other Healthcare Services) 18-Aug-2020 Later Stage VC 0000 Other Healthcare Services Generating Revenue
You’re viewing 10 of 360 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

F-Prime Capital Exits (99)

Company Name Exit Date Exit Type Exit Size
TradeBlock 05-Jan-2021 Merger/Acquisition
0000 000000000000 01-Oct-2020 000000 0000000000 00000
000000000 01-Sep-2020 000000000000000000 00000
0000000 12-Aug-2020 0000000000
000000000 00000000 07-Aug-2020 000 0000
000000000 29-Jul-2020 000 00000
00000 09-Jul-2020 000000000000000000
0000000 0000000000 12-Jun-2020 000 00000
Beam Therapeutics 05-Feb-2020 IPO 00000
Denali Therapeutics 28-Jan-2020 Secondary Transaction - Open Market 00000
You’re viewing 10 of 99 exits. Get the full list »

F-Prime Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

F-Prime Capital Team (88)

Name Title Deals Funds Boards Office
Stephen Knight MD President & Managing Partner 00 0 00 Cambridge, MA
Stacie Weninger Ph.D President, FBRI 0 0 Cambridge, MA
Mary Pendergast Partner & Chief Operating Officer Cambridge, MA
Adrienne Harris JD Venture Partner 0 San Francisco, CA
Amber Cai Ph.D Venture Partner China
You’re viewing 5 of 88 team members. Get the full list »

F-Prime Capital Co-Investors (531)

Name With Exits Lead Partner Series Industry
Eight Roads 58 0 00 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
Maverick Ventures 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 531 co-investors. Get the full list »